FY26 Results Meet Expectations; Medium-Term Capital Returns and Buyback Capacity Support the “Buy” View

Overview

Goldman Sachs maintains its Buy rating on Challenger Ltd. and its 12-month target price of A$11.50. FY26 normalized results broadly met expectations, with resilient capital returns, sales and book growth in the annuity business, and improved net inflows in funds management. The company's updated medium-term ROE, EPS growth, capital and dividend frameworks are broadly consistent with expectations, while ample capital supports buybacks and dividends.

Core views

The core view is that medium-term fundamentals continue to offer upside potential: the medium-term operating ROE target of 12%-14%, EPS growth target of 8%-10%, and lower capital target range all support improved capital returns. Although FY27 earnings guidance is below Goldman Sachs and market expectations, the underlying operational drag is limited after excluding one-off items such as the establishment of Calix Re and the Fidante/Channel merger. The company benefits from Australia's superannuation market, the retail annuity sales environment, diversified distribution channels and abundant capital.

Analysis framework

The report compares FY26 actual results against company guidance, Goldman Sachs forecasts and market consensus, and assesses operating quality across ROE, COE margin, annuity book growth, asset allocation, capital adequacy, expenses and funds-management net inflows. The target price uses a weighted combination of fundamental and M&A valuations.

Methodology notes

• Valuation methodsWeighted Target Price Valuation

  Weighted fundamental and M&A valuations

  The 12-month target price of A$11.50 comprises 85% fundamental value and 15% M&A value.

• Valuation methodsDCF and NTA Multiple Method

  Fundamental valuation

  Within fundamental value, 50% is based on DCF and 50% on an NTA multiple; the NTA multiple references the regression relationship between FY28E sustainable ROTE and P/NTA within the financial coverage universe.

• Valuation methodsPrice-to-Earnings Method

  M&A value

  M&A valuation uses a 15x P/E multiple, approximately in line with the peak valuation multiple over the past five years.

• Operating AnalysisROE and Margin Benchmarking

  Earnings quality assessment

  Operating performance and medium-term earnings capacity are assessed by comparing normalized ROE, COE margin, expense-to-income ratio and EPS with forecasts and targets.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• CGF.AX

  Covered Company

  Strengths

  A leading Australian retail and institutional annuity provider, benefiting from the superannuation market, annuity book growth, diversified sales channels, funds-management net inflows and significant excess capital.

  Weaknesses

  FY27 guidance is below Goldman Sachs and market expectations; a higher fixed-income allocation may reduce margins, while operating expenses are also slightly above expectations.

  Comparison

  FY26 normalized NPAT, basic EPS and COE margin broadly met or slightly exceeded Goldman Sachs and market expectations, but implied FY27 normalized EPS of 70.9cps is below Goldman Sachs' 74.4cps and the market's 75.2cps.

  Risks

  Growth through channels or products that dilute margins or ROE; new entrants intensifying price competition through changes in capital standards; weak demand for annuity products.

Key data

• FY26 Normalized NPATA$467.6mAt the midpoint of the A$455-480m guidance range; 2H26 was A$238.7m, above Goldman Sachs' forecast of A$237.8m.
• FY26 Normalized Basic EPS68.1cpsAt the midpoint of the 66-70cps guidance range; 2H26 was 34.8cps, slightly above Goldman Sachs' 34.7cps.
• 2H26 Normalized ROE11.7%Above the target level of approximately 11.2%.
• Medium-Term Operating ROE Target12%-14%Set under the new capital standard as the medium-term earnings-capacity framework.
• Medium-Term EPS Growth Target8%-10%Broadly consistent with market expectations based on normalized EPS, with the scale of buybacks potentially providing additional upside.
• Implied FY27 Normalized EPS70.9cpsBelow Goldman Sachs' 74.4cps and the market's 75.2cps; one-off items are the primary source of the gap.
• 2H26 COE Margin3.17%Above Goldman Sachs' 3.11% and the market's 3.09%.
• Additional Share BuybackA$300mNewly added on top of the ongoing A$150m buyback.
• Capital Target Range1.15-1.35xReduced from 1.3-1.7x; closing capital position under the new capital standard was 1.50x.
• FY26 Ordinary Dividend Payout Ratio46.3%Excludes the 1.5cps special dividend; the new target is 65%-75% of core basic EPS.
• 4Q26 Funds Under ManagementA$108.7bnQuarterly net inflows were A$1.342bn, a material improvement from net outflows of A$6.6bn in the prior-year period.

Impact & implications

The results reinforce Goldman Sachs' positive view of the company's medium-term capital returns and capital-management capabilities. Additional buybacks, a special dividend and a lower capital target range can enhance shareholder returns; if market expectations do not fully reflect book growth driven by buybacks or capital release, EPS still has upside potential. The near term requires accepting weaker underlying FY27 growth and margin pressure from asset-allocation adjustments, but the report considers these factors insufficient to alter the long-term investment thesis.

Risks

• Growth derived from channels and products that dilute margins or ROE could weaken return improvement.
• Changes in capital standards could lower barriers to entry and intensify price competition.
• Retail or institutional annuity demand below expectations would affect sales and book growth.
• Higher fixed-income allocations and tighter credit spreads may pressure COE margins.
• Investment performance was highly volatile: 2H26 post-tax investment experience was -A$62.4m, materially below Goldman Sachs and market expectations.
• The Fidante and Channel Capital merger remains subject to regulatory approval and closing conditions, creating uncertainty around integration costs and timing.
• Australian dollar appreciation against sterling and higher UK gilt yields have reduced the PVPM of the life risk portfolio.

What to watch

• Whether FY27 core basic EPS falls within the 45-49cps guidance range, and the actual scale of one-off transformation and transaction costs.
• The execution pace and completion status of the new A$300m buyback and existing A$150m buyback, and their impact on the capital position.
• Whether the capital position can remain near the new 1.15-1.35x target range, and management's capital-allocation trade-off between growth and buybacks.
• The path for operating ROE to rise toward the medium-term target of 12%-14%.
• Changes in annuity book growth, retail sales, maturity rates and long-duration business sales.
• COE margins and investment yields following an increased allocation to investment-grade fixed income.
• Whether the Fidante and Channel Capital merger can be completed by the end of 1H27, and its impact on funds under management, inflows and earnings.
• Whether net inflows and FUM growth in the funds-management business can continue.